BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24707046)

  • 1. Silencing of the EPHB3 tumor-suppressor gene in human colorectal cancer through decommissioning of a transcriptional enhancer.
    Jägle S; Rönsch K; Timme S; Andrlová H; Bertrand M; Jäger M; Proske A; Schrempp M; Yousaf A; Michoel T; Zeiser R; Werner M; Lassmann S; Hecht A
    Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4886-91. PubMed ID: 24707046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNAIL1 combines competitive displacement of ASCL2 and epigenetic mechanisms to rapidly silence the EPHB3 tumor suppressor in colorectal cancer.
    Rönsch K; Jägle S; Rose K; Seidl M; Baumgartner F; Freihen V; Yousaf A; Metzger E; Lassmann S; Schüle R; Zeiser R; Michoel T; Hecht A
    Mol Oncol; 2015 Feb; 9(2):335-54. PubMed ID: 25277775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression Profile and Prognostic Significance of EPHB3 in Colorectal Cancer.
    Jang BG; Kim HS; Bae JM; Kim WH; Hyun CL; Kang GH
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32294981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class I and III HDACs and loss of active chromatin features contribute to epigenetic silencing of CDX1 and EPHB tumor suppressor genes in colorectal cancer.
    Rönsch K; Jäger M; Schöpflin A; Danciu M; Lassmann S; Hecht A
    Epigenetics; 2011 May; 6(5):610-22. PubMed ID: 21393996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Notch-2 gene is regulated by Wnt signaling in cultured colorectal cancer cells.
    Ungerbäck J; Elander N; Grünberg J; Sigvardsson M; Söderkvist P
    PLoS One; 2011 Mar; 6(3):e17957. PubMed ID: 21437251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells.
    Chiu ST; Chang KJ; Ting CH; Shen HC; Li H; Hsieh FJ
    Carcinogenesis; 2009 Sep; 30(9):1475-86. PubMed ID: 19483190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCF7L1 Modulates Colorectal Cancer Growth by Inhibiting Expression of the Tumor-Suppressor Gene EPHB3.
    Murphy M; Chatterjee SS; Jain S; Katari M; DasGupta R
    Sci Rep; 2016 Jun; 6():28299. PubMed ID: 27333864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The wnt target jagged-1 mediates the activation of notch signaling by progastrin in human colorectal cancer cells.
    Pannequin J; Bonnans C; Delaunay N; Ryan J; Bourgaux JF; Joubert D; Hollande F
    Cancer Res; 2009 Aug; 69(15):6065-73. PubMed ID: 19622776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sonic hedgehog pathway activation is associated with cetuximab resistance and EPHB3 receptor induction in colorectal cancer.
    Park SH; Jo MJ; Kim BR; Jeong YA; Na YJ; Kim JL; Jeong S; Yun HK; Kim DY; Kim BG; Kang SH; Oh SC; Lee DH
    Theranostics; 2019; 9(8):2235-2251. PubMed ID: 31149041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer.
    Rodilla V; Villanueva A; Obrador-Hevia A; Robert-Moreno A; Fernández-Majada V; Grilli A; López-Bigas N; Bellora N; Albà MM; Torres F; Duñach M; Sanjuan X; Gonzalez S; Gridley T; Capella G; Bigas A; Espinosa L
    Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6315-20. PubMed ID: 19325125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
    Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
    Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor Tyrosine Kinase EphB3: a Prognostic Indicator in Colorectal Carcinoma.
    Xuan Z; Huang J; Gao L; Wang Y; Wang J; Sun Y
    Pathol Oncol Res; 2020 Jan; 26(1):541-549. PubMed ID: 30535864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R-spondin1/Wnt-enhanced Ascl2 autoregulation controls the self-renewal of colorectal cancer progenitor cells.
    Ye J; Liu S; Shang Y; Chen H; Wang R
    Cell Cycle; 2018; 17(8):1014-1025. PubMed ID: 29886802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB.
    Batlle E; Henderson JT; Beghtel H; van den Born MM; Sancho E; Huls G; Meeldijk J; Robertson J; van de Wetering M; Pawson T; Clevers H
    Cell; 2002 Oct; 111(2):251-63. PubMed ID: 12408869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.
    Kang DW; Min do S
    PLoS One; 2010 Aug; 5(8):e12109. PubMed ID: 20711340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hes1: a key role in stemness, metastasis and multidrug resistance.
    Liu ZH; Dai XM; Du B
    Cancer Biol Ther; 2015; 16(3):353-9. PubMed ID: 25781910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.
    Konsavage WM; Kyler SL; Rennoll SA; Jin G; Yochum GS
    J Biol Chem; 2012 Apr; 287(15):11730-9. PubMed ID: 22337891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Enhancer-Driven Stem Cell-Like Program Mediated by SOX9 Blocks Intestinal Differentiation in Colorectal Cancer.
    Liang X; Duronio GN; Yang Y; Bala P; Hebbar P; Spisak S; Sahgal P; Singh H; Zhang Y; Xie Y; Cejas P; Long HW; Bass AJ; Sethi NS
    Gastroenterology; 2022 Jan; 162(1):209-222. PubMed ID: 34571027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EphB3 Stimulates Cell Migration and Metastasis in a Kinase-dependent Manner through Vav2-Rho GTPase Axis in Papillary Thyroid Cancer.
    Li JJ; Sun ZJ; Yuan YM; Yin FF; Bian YG; Long LY; Zhang XL; Xie D
    J Biol Chem; 2017 Jan; 292(3):1112-1121. PubMed ID: 27986811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.